Insufficient scRNA-seq data for expression of DCD at single-cell level.
Insufficient scRNA-seq data for expression of DCD at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| skin | 75% | 34182.31 | 1363 / 1809 | 4% | 9.92 | 18 / 472 |
| breast | 45% | 160.41 | 207 / 459 | 25% | 278.20 | 281 / 1118 |
| adipose | 44% | 1513.00 | 530 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 37% | 41.33 | 499 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 34% | 56.02 | 273 / 803 | 0% | 0 | 0 / 0 |
| heart | 29% | 13.04 | 252 / 861 | 0% | 0 | 0 / 0 |
| esophagus | 24% | 10.53 | 343 / 1445 | 1% | 0.02 | 2 / 183 |
| intestine | 24% | 13.88 | 229 / 966 | 1% | 0.02 | 5 / 527 |
| lung | 24% | 13.20 | 140 / 578 | 0% | 0.01 | 5 / 1155 |
| stomach | 22% | 10.40 | 78 / 359 | 3% | 0.05 | 8 / 286 |
| pancreas | 22% | 9.79 | 72 / 328 | 0% | 0 | 0 / 178 |
| peripheral blood | 22% | 8.47 | 203 / 929 | 0% | 0 | 0 / 0 |
| liver | 22% | 10.54 | 49 / 226 | 0% | 0 | 0 / 406 |
| thymus | 22% | 8.94 | 141 / 653 | 0% | 0 | 0 / 605 |
| ovary | 21% | 7.47 | 37 / 180 | 1% | 0.15 | 4 / 430 |
| prostate | 21% | 6.51 | 51 / 245 | 0% | 0 | 0 / 502 |
| adrenal gland | 17% | 7.35 | 45 / 258 | 0% | 0 | 0 / 230 |
| uterus | 16% | 5.79 | 27 / 170 | 1% | 0.05 | 6 / 459 |
| brain | 15% | 6.56 | 408 / 2642 | 1% | 0.02 | 5 / 705 |
| kidney | 15% | 3.82 | 13 / 89 | 1% | 0.09 | 11 / 901 |
| spleen | 16% | 7.09 | 38 / 241 | 0% | 0 | 0 / 0 |
| bladder | 14% | 2.29 | 3 / 21 | 0% | 0.05 | 2 / 504 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0034220 | Biological process | monoatomic ion transmembrane transport |
| GO_0050832 | Biological process | defense response to fungus |
| GO_0051873 | Biological process | killing by host of symbiont cells |
| GO_0006508 | Biological process | proteolysis |
| GO_0042742 | Biological process | defense response to bacterium |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005576 | Cellular component | extracellular region |
| GO_0016020 | Cellular component | membrane |
| GO_0008233 | Molecular function | peptidase activity |
| GO_0005216 | Molecular function | monoatomic ion channel activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0008289 | Molecular function | lipid binding |
| GO_0046872 | Molecular function | metal ion binding |
| GO_0003723 | Molecular function | RNA binding |
| Gene name | DCD |
| Protein name | Dermcidin (EC 3.4.-.-) (Preproteolysin) [Cleaved into: Survival-promoting peptide; DCD-1] |
| Synonyms | DSEP AIDD |
| Description | FUNCTION: [DCD-1]: Found in sweat, has an antimicrobial activity during early bacterial colonization . The secreted peptide assembles into homohexameric complexes that can associate with and also insert into pathogen membranes . Once inserted in bacteria membranes forms anion channels probably altering the transmembrane potential essential for bacterial survival . Highly effective against E.coli, E.faecalis, S.aureus and C.albicans . Optimal pH and salt concentration resemble the conditions in sweat . Also exhibits proteolytic activity, cleaving on the C-terminal side of Arg and, to a lesser extent, Lys residues . .; FUNCTION: [Survival-promoting peptide]: Promotes survival of neurons and displays phosphatase activity . It may bind IgG . . |
| Accessions | ENST00000456047.2 [P81605-2] ENST00000293371.11 [P81605-1] ENST00000546807.5 [P81605-3] P81605 |